News from NORD

Neuroendocrine Tumor Research Foundation Issues Request for Proposals


 

The Neuroendocrine Tumor Research Foundation (NETRF) has issued an invitation for Letters of Intent for 2017 research grants . Proposals are being sought with the potential to transform understanding of neuroendocrine tumors and/or lead to improved treatments and diagnostics for patients. Letters of Intent may focus on any type of neuroendocrine tumor and may be for basic, translational, or clinical research.

Recommended Reading

FDA Commissioner to Present Keynote Address at NORD Summit
MDedge Hematology and Oncology
Examining the Role of Caregivers at NINR Caregiving Summit
MDedge Hematology and Oncology
FDA Launches Expanded Access Navigator
MDedge Hematology and Oncology
Columbia Neurosurgery Article Highlights Medical Expert’s Support for NORD Patient Information
MDedge Hematology and Oncology
AA MDS Offers Webinar Series
MDedge Hematology and Oncology
NORD Welcomes All Things Kabuki as New Member
MDedge Hematology and Oncology
Alpha-1 Foundation Announces Funding Opportunities
MDedge Hematology and Oncology
cureCADASIL Announces Publication of Study Results
MDedge Hematology and Oncology
Hyper IgM Foundation Publishes Blog
MDedge Hematology and Oncology
MSA Coalition Plans Patient/Family Conference
MDedge Hematology and Oncology